# The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer

> **NCT00188604** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 34 (estimated)

## Conditions studied

- Breast Neoplasms
- Lymphedema

## Interventions

- **DRUG:** sodium selenite

## Key facts

- **NCT ID:** NCT00188604
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2010-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00188604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00188604, "The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00188604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*